共 50 条
- [42] Renal dysfunction is associated with increased risk of fatal and non-fatal cardiovascular events in patients with heart failure and preserved ejection fraction - Findings from the irbesartan in heart failure with preserved Systolic function trial (I-Preserve) CIRCULATION, 2007, 116 (16) : 552 - 552
- [46] Systematic review and meta-analysis of stroke and thromboembolism risk in atrial fibrillation with preserved vs. reduced ejection fraction heart failure BMC CARDIOVASCULAR DISORDERS, 2024, 24 (01):